Article
Amgen, Merck, Teva Provide First-Quarter Biosimilars Info
Rating:
0.0
Views:
110
Likes:
1
Library:
1
There's no end in sight for Enbrel (etanercept) sales erosion, but Amgen's biosimilars are holding their own, the company reported.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value